The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Lifetime Prevalence, Age of Risk, and Genetic Relationships of Comorbid Psychiatric Disorders in Tourette Syndrome
Open accessAbstract
IMPORTANCE: Tourette syndrome (TS) is characterized by high rates of psychiatric comorbidity; however, few studies have fully characterized these comorbidities. Furthermore, most studies have included relatively few participants (<200), and none has examined the ages of highest risk for each TS-associated comorbidity or their etiologic relationship to TS. OBJECTIVE: To characterize the lifetime prevalence, clinical associations, ages of highest risk, and etiology of psychiatric comorbidity among individuals with TS. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional structured diagnostic interviews conducted between April 1, 1992, and December 31, 2008, of participants with TS (n = 1374) and TS-unaffected family members (n = 1142). MAIN OUTCOMES AND MEASURES: Lifetime prevalence of comorbid DSM-IV-TR disorders, their heritabilities, ages of maximal risk, and associations with symptom severity, age at onset, and parental psychiatric history. RESULTS: The lifetime prevalence of any psychiatric comorbidity among individuals with TS was 85.7%; 57.7% of the population had 2 or more psychiatric disorders. The mean (SD) number of lifetime comorbid diagnoses was 2.1 (1.6); the mean number was 0.9 (1.3) when obsessive-compulsive disorder (OCD) and attention-deficit/hyperactivity disorder (ADHD) were excluded, and 72.1% of the individuals met the criteria for OCD or ADHD. Other disorders, including mood, anxiety, and disruptive behavior, each occurred in approximately 30% of the participants. The age of greatest risk for the onset of most comorbid psychiatric disorders was between 4 and 10 years, with the exception of eating and substance use disorders, which began in adolescence (interquartile range, 15-19 years for both). Tourette syndrome was associated with increased risk of anxiety (odds ratio [OR], 1.4; 95% CI, 1.0-1.9; P = .04) and decreased risk of substance use disorders (OR, 0.6; 95% CI, 0.3-0.9; P = .02) independent from comorbid OCD and ADHD; however, high rates of mood disorders among participants with TS (29.8%) may be accounted for by comorbid OCD (OR, 3.7; 95% CI, 2.9-4.8; P < .001). Parental history of ADHD was associated with a higher burden of non-OCD, non-ADHD comorbid psychiatric disorders (OR, 1.86; 95% CI, 1.32-2.61; P < .001). Genetic correlations between TS and mood (RhoG, 0.47), anxiety (RhoG, 0.35), and disruptive behavior disorders (RhoG, 0.48), may be accounted for by ADHD and, for mood disorders, by OCD. CONCLUSIONS AND RELEVANCE: This study is, to our knowledge, the most comprehensive of its kind. It confirms the belief that psychiatric comorbidities are common among individuals with TS, demonstrates that most comorbidities begin early in life, and indicates that certain comorbidities may be mediated by the presence of comorbid OCD or ADHD. In addition, genetic analyses suggest that some comorbidities may be more biologically related to OCD and/or ADHD rather than to TS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since TS is seldom seen without comorbidities [1], co-occurring ADHD, OCD, other anxiety disorders or mood disorders were included, unless the disorder required immediate treatment or change in current treatment.”
From Tackle your Tics: pilot findings of a brief, intensive group-based exposure therapy program for children with tic disorders (2021) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
Multipoint Quantitative-Trait Linkage Analysis in General Pedigrees
Almasy, L., & Blangero, J. (1998) · The American Journal of Human Genetics · doi:10.1086/301844 · Cited by 3,028
(2007) · PubMed Central · Cited by 2,521
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs
Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) · Nature Genetics · doi:10.1038/ng.2711 · Cited by 2,263
The yale global tic severity scale: initial testing of a clinician-rated scale of tic severity
LECKMAN, J. F., RIDDLE, M. A., HARDIN, M. T., ORT, S. I., SWARTZ, K. L., STEVENSON, J., & COHEN, D. J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198907000-00015 · Cited by 2,146
Best Estimate of Lifetime Psychiatric Diagnosis: A Methodological Study
Leckman, J. F. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290080001001 · Cited by 1,425
Freeman, R. D., Fast, D. K., Burd, L., Kerbeshian, J., Robertson, M. M., & Sandor, P. (2000) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200000839 · Cited by 924
Self-citation
Cited by
Pringsheim, T., Okun, M. S., Müller-Vahl, K., Martino, D., Jankovic, J., Cavanna, A. E., Woods, D. W., Robinson, M., Jarvie, E., Roessner, V., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007466 · Cited by 565
Gilles de la Tourette syndrome
Robertson, M. M., Eapen, V., Singer, H. S., Martino, D., Scharf, J. M., Paschou, P., Roessner, V., Woods, D. W., Hariz, M., Mathews, C. A., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.97 · Cited by 347
Self-citationDe Novo Coding Variants Are Strongly Associated with Tourette Disorder
Willsey, A. J., Fernandez, T. V., Yu, D., King, R. A., Dietrich, A., Xing, J., Sanders, S. J., Mandell, J. D., Huang, A. Y., Richer, P., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.04.024 · Cited by 187
Self-citationRapid Onset Functional Tic‐Like Behaviors in Young Females During the COVID‐19 Pandemic
Pringsheim, T., Ganos, C., McGuire, J. F., Hedderly, T., Woods, D., Gilbert, D. L., Piacentini, J., Dale, R. C., & Martino, D. (2021) · Movement Disorders · doi:10.1002/mds.28778 · Cited by 133
Tics and functional tic-like movements: Can we tell them apart?
Ganos, C., Martino, D., Espay, A. J., Lang, A. E., Bhatia, K. P., & Edwards, M. J. (2019) · Neurology · doi:10.1212/wnl.0000000000008372 · Cited by 124
Neutrophil-lymphocyte ratios as inflammatory biomarkers in psychiatric patients
Bhikram, T., & Sandor, P. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.07.006 · Cited by 103
Self-citationThe female Tourette patient: Sex differences in Tourette Disorder
Garris, J., & Quigg, M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.08.001 · Cited by 80
Differential binding of antibodies in PANDAS patients to cholinergic interneurons in the striatum
Frick, L. R., Rapanelli, M., Jindachomthong, K., Grant, P., Leckman, J. F., Swedo, S., Williams, K., & Pittenger, C. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.12.004 · Cited by 70
Predictors of the clinical course of Tourette syndrome: a longitudinal study.
Groth, C., Skov, L., Lange, T., & Debes, N. M. (2019) · Journal of Child Neurology · doi:10.1177/0883073819867245 · Cited by 58
Novel psychological formulation and treatment of “tic attacks” in Tourette syndrome
Robinson, S., & Hedderly, T. (2016) · Frontiers in Pediatrics · doi:10.3389/fped.2016.00046 · Cited by 53
A transdiagnostic approach to neurodiversity in a representative population sample: The N+ 4 model
Apperly, I. A., Lee, R., van der Kleij, S. W., & Devine, R. T. (2024) · JCPP Advances · doi:10.1002/jcv2.12219 · Cited by 37
Martindale, J. M., & Mink, J. W. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.863919 · Cited by 34
“Some studies have reported TS-affected females have later onset of tics (16, 33, 34), later peak of tic severity (29, 34), motor tic severity (32, 33), and lower likelihood of tic remission; however, others have shown conflicting results or no significant sex-differences in these factors (18, 28, 32, 33, 35).”
BackgroundResultHeijerman-Holtgrefe, A. P., Verdellen, C. W. J., van de Griendt, J. M. T. M., Beljaars, L. P. L., Kan, K. J., Cath, D., Hoekstra, P. J., Huyser, C., & Utens, E. M. W. J. (2021) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01532-5 · Cited by 33
Self-citation(2022) · PubMed Central · Cited by 20
Greenberg, E., Albright, C., Hall, M., Hoeppner, S., Miller, S., Farley, A., Silverman, M., Braddick, V., Sprich, S., & Wilhelm, S. (2023) · Behavior Therapy · doi:10.1016/j.beth.2022.07.007 · Cited by 11
Murayama, K., Tomiyama, H., Sashikata, K., Kang, M., Ohno, A., Kato, K., Matsuo, A., & Nakao, T. (2026) · Journal of Neuropsychology · doi:10.1111/jnp.70016 · Cited by 1
Metadata
- Authors
- Hirschtritt, M. E., Lee, P. C., Pauls, D. L., Dion, Y., Grados, M. A., Illmann, C., King, R. A., Sandor, P., McMahon, W. M., Lyon, G. J., Cath, D. C., Kurlan, R., Robertson, M. M., Osiecki, L., Scharf, J. M., & Mathews, C. A.
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2015-04-01
- Volume
- 72
- Issue
- 4
- Pages
- 325
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W2108710427
- Cited by
- 770
- References
- 52
- FWCI
- 59.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.